Europe’s drug regulator has more questions about the safety and potential risks of a new, widely popular class of medicines....
Medicine
Flagship Pioneering is looking to raise $3 billion for its eighth venture fund, a sign the high-profile company creator continues...
AbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion deal to acquire ImmunoGen, a pioneer...
Dive Brief: Cigna and Humana are in talks to merge, according to the Wall Street Journal. The two health insurers...
Dive Brief: Gilead Sciences is laying off about 7% of employees at cell therapy unit Kite Pharma in a restructuring...
The Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’ Kymriah or Gilead’s Yescarta are linked to...
Bristol Myers Squibb has agreed to spend at least $100 million to expand a partnership aimed at creating RNA-based medicines...
Dive Brief: GSK on Monday said its drug Blenrep outperformed Johnson & Johnson’s Darzalex in a clinical trial of people...
Dive Brief: Novo Nordisk on Thursday said it will invest more than 16 billion Danish kroner, or about $2.3 billion,...